These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34297039)

  • 1. ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses.
    Herzner AM; Khan Z; Van Nostrand EL; Chan S; Cuellar T; Chen R; Pechuan-Jorge X; Komuves L; Solon M; Modrusan Z; Haley B; Yeo GW; Behrens TW; Albert ML
    J Exp Med; 2021 Sep; 218(9):. PubMed ID: 34297039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAR regulates APOL1 via A-to-I RNA editing by inhibition of MDA5 activation in a paradoxical biological circuit.
    Riella CV; McNulty M; Ribas GT; Tattersfield CF; Perez-Gill C; Eichinger F; Kelly J; Chun J; Subramanian B; Guizelini D; ; Alper SL; Pollak MR; Sampson MG; Friedman DJ
    Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2210150119. PubMed ID: 36282916
    [No Abstract]   [Full Text] [Related]  

  • 3. ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation.
    de Reuver R; Dierick E; Wiernicki B; Staes K; Seys L; De Meester E; Muyldermans T; Botzki A; Lambrecht BN; Van Nieuwerburgh F; Vandenabeele P; Maelfait J
    Cell Rep; 2021 Aug; 36(6):109500. PubMed ID: 34380029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.
    Chung H; Calis JJA; Wu X; Sun T; Yu Y; Sarbanes SL; Dao Thi VL; Shilvock AR; Hoffmann HH; Rosenberg BR; Rice CM
    Cell; 2018 Feb; 172(4):811-824.e14. PubMed ID: 29395325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAR1, inosine and the immune sensing system: distinguishing self from non-self.
    Liddicoat BJ; Chalk AM; Walkley CR
    Wiley Interdiscip Rev RNA; 2016; 7(2):157-72. PubMed ID: 26692549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do editors do? Understanding the physiological functions of A-to-I RNA editing by adenosine deaminase acting on RNAs.
    Heraud-Farlow JE; Walkley CR
    Open Biol; 2020 Jul; 10(7):200085. PubMed ID: 32603639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DHX9 suppresses RNA processing defects originating from the Alu invasion of the human genome.
    Aktaş T; Avşar Ilık İ; Maticzka D; Bhardwaj V; Pessoa Rodrigues C; Mittler G; Manke T; Backofen R; Akhtar A
    Nature; 2017 Apr; 544(7648):115-119. PubMed ID: 28355180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself.
    Liddicoat BJ; Piskol R; Chalk AM; Ramaswami G; Higuchi M; Hartner JC; Li JB; Seeburg PH; Walkley CR
    Science; 2015 Sep; 349(6252):1115-20. PubMed ID: 26275108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways.
    Nakahama T; Kawahara Y
    Int Immunol; 2023 Mar; 35(3):123-133. PubMed ID: 36469491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response.
    Wu Y; Zhao W; Liu Y; Tan X; Li X; Zou Q; Xiao Z; Xu H; Wang Y; Yang X
    EMBO J; 2018 Dec; 37(23):. PubMed ID: 30158112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editor meets silencer: crosstalk between RNA editing and RNA interference.
    Nishikura K
    Nat Rev Mol Cell Biol; 2006 Dec; 7(12):919-31. PubMed ID: 17139332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte-macrophage crosstalk via the PGRN-EGFR axis modulates ADAR1-mediated immunity in the liver.
    Gan WL; Ren X; Ng VHE; Ng L; Song Y; Tano V; Han J; An O; Xie J; Ng BYL; Tay DJT; Tang SJ; Shen H; Khare S; Chong KHC; Young DY; Wu B; DasGupta R; Chen L
    Cell Rep; 2024 Jul; 43(7):114400. PubMed ID: 38935501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA editing underlies genetic risk of common inflammatory diseases.
    Li Q; Gloudemans MJ; Geisinger JM; Fan B; Aguet F; Sun T; Ramaswami G; Li YI; Ma JB; Pritchard JK; Montgomery SB; Li JB
    Nature; 2022 Aug; 608(7923):569-577. PubMed ID: 35922514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To "Z" or not to "Z": Z-RNA, self-recognition, and the MDA5 helicase.
    Herbert A
    PLoS Genet; 2021 May; 17(5):e1009513. PubMed ID: 33983939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All I's on the RADAR: role of ADAR in gene regulation.
    Shevchenko G; Morris KV
    FEBS Lett; 2018 Sep; 592(17):2860-2873. PubMed ID: 29770436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the Biological Significance of ADAR1-Z-RNA Interactions.
    Nakahama T; Kawahara Y
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAR1: A New Target for Immuno-oncology Therapy.
    Bhate A; Sun T; Li JB
    Mol Cell; 2019 Mar; 73(5):866-868. PubMed ID: 30849393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALU A-to-I RNA Editing: Millions of Sites and Many Open Questions.
    Schaffer AA; Levanon EY
    Methods Mol Biol; 2021; 2181():149-162. PubMed ID: 32729079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
    Ganem NS; Ben-Asher N; Lamm AT
    Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation.
    de Reuver R; Verdonck S; Dierick E; Nemegeer J; Hessmann E; Ahmad S; Jans M; Blancke G; Van Nieuwerburgh F; Botzki A; Vereecke L; van Loo G; Declercq W; Hur S; Vandenabeele P; Maelfait J
    Nature; 2022 Jul; 607(7920):784-789. PubMed ID: 35859175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.